Fingerprint
Dive into the research topics of 'Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Value of accelerated multimodality therapy in stage IIIA and IIIB non-small cell lung cancer
Malcolm M. DeCamp*, Thomas W. Rice, David J. Adelstein, Mark A. Chidel, Lisa A. Rybicki, Sudish C. Murthy, Eugene H. Blackstone, Robert Ginsberg, Douglas J. Mathisen
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations